Clearstead Trust’s Chemours CC Stock Holding History

Clearstead Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-23	Closed	-$604	–	433
2024 Q1	$604	Buy	+23	New	+$655	﹤0.01%	423

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Clearstead Trust's CC Position: Q2 2024 in Review

Clearstead Trust sold out of Chemours (CC) in Q2 2024, closing a stake of 23 shares — an estimated $604 sold.

Clearstead Trust first reported a position in CC in Q1 2024 and held it in 1 quarter. The position peaked at $604 in Q1 2024. 435 funds tracked by Wall St. Rank hold CC as of Q2 2024.

Clearstead Trust reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
Clearstead Trust sold 23 Chemours shares in Q2 2024, an estimated $604.
Clearstead Trust first reported a position in Chemours in Q1 2024 and held it in 1 quarter.
Clearstead Trust's Chemours position peaked at $604 in Q1 2024.
435 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Clearstead Trust's 13F filing for Q2 2024, filed 9 Aug 2024.